Medicines Australia will be appointing a new chair. To what extent does it matter? The participation model means that the industry might be effectively shackled to the 'change' table rather than having a seat at it. The government has worked it out, constantly increasing the price of participation and limiting exclusionary discussions about change. How does that need to change?

Latest Video
New Stories
-
The 'Dispatched' week in review podcast - 7 March
March 7, 2025 - - Podcast -
Kosi Challenge fundraising total races past $400,000 as Pharma Cup teams add to totals
March 7, 2025 - - Latest News -
Women twice as likely as men to skip a prescription because of cost
March 7, 2025 - - Latest News -
Omico welcomes new government investment in precision medical trial
March 7, 2025 - - Latest News -
Five pharma companies recognised amongst Australia’s Best Workplaces for Women
March 7, 2025 - - Latest News -
Version 20 of Medicines Australia code takes PR back to the future
March 7, 2025 - - Latest News -
AusBiotech and Medicines Australia gather for International Women’s Day
March 6, 2025 - - Latest News